Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
P WhiteA Frew

Abstract

Seasonal allergic rhinitis is often regarded as a trivial condition which patients should treat themselves. However, a significant proportion of sufferers are not fully controlled on standard hay fever medication, either because they do not use it properly or because their symptoms are resistant to standard therapy. The latter group may be suitable for allergen immunotherapy, which was once widely available in UK general practice but is now only available through specialist centres. To describe the symptom control of patients with hay fever, to assess concordance with prescribed medication, and to estimate the number of patients who may benefit from referral for allergen immunotherapy. General practices in Hampshire and Dorset, UK. Survey of adult hay fever sufferers prescribed a non-sedating antihistamine and nasal steroid spray by their general practitioner. A postal questionnaire was sent to all eligible patients aged 16-64 registered with 16 general practices. Self-assessment of symptom control and reported compliance with medication were used to identify those patients who were suboptimally controlled and might therefore benefit from immunotherapy. Eight hundred and forty-six out of 62500 registered patients aged 16-64 (1....Continue Reading

References

Apr 4, 1992·BMJ : British Medical Journal·J Britton
Oct 1, 1989·Archives of Disease in Childhood·M L BurrE Vaughan-Williams
Feb 1, 1994·American Journal of Respiratory and Critical Care Medicine·J BousquetF B Michel
May 10, 1997·BMJ : British Medical Journal·A Parikh, G K Scadding
Oct 11, 1986·British Medical Journal

❮ Previous
Next ❯

Citations

Mar 9, 2005·The Journal of Allergy and Clinical Immunology·Jill A PooleLanny J Rosenwasser
Oct 3, 2002·Allergy·E HamelmannU Wahn
Dec 21, 2000·Clinical Otolaryngology and Allied Sciences·G K ScaddingM J Price
May 24, 2008·The New England Journal of Medicine·Anthony J Frew
Nov 1, 2012·Clinical and Translational Allergy·Moises A CalderonNikolaos Papadopoulos
Oct 29, 2010·Current Medical Research and Opinion·Linda Cox, Moises A Calderon
Apr 17, 2012·Current Medical Research and Opinion·Harold NelsonMichael S Blaiss
Feb 9, 2016·The Journal of Allergy and Clinical Immunology·Stephen R Durham, Martin Penagos
Sep 4, 2015·Drug Discovery Today·Jørgen Nedergaard LarsenHenrik Jacobi
Apr 6, 2013·The Journal of Allergy and Clinical Immunology·Janine DretzkeCatherine Meads
Mar 5, 2010·The Journal of Allergy and Clinical Immunology·Anthony J Frew
Aug 8, 2009·The Journal of Allergy and Clinical Immunology·Jean BousquetUNKNOWN Extended Global Allergy and Asthma European Network, World Allergy Organization and Allergic Rhinitis and its Impact on Asth
Apr 1, 2008·The Journal of Allergy and Clinical Immunology·James N FrancisStephen J Till
Dec 25, 2007·The Journal of Allergy and Clinical Immunology·Ronald DahlStephen R Durham
Nov 22, 2007·The Journal of Allergy and Clinical Immunology·Thomas B CasaleEgilius L H Spierings
Apr 17, 2016·Immunology and Allergy Clinics of North America·David I BernsteinJonathan A Bernstein
Jun 23, 2005·Allergy·D InführG Achatz
May 3, 2006·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M L BarnesB J Lipworth
Dec 16, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D I PritchardS J Till
Jul 23, 2013·International Forum of Allergy & Rhinology·Sammy KhaliliBrian Rotenberg
Apr 27, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P DemolyF-A Allaert
Apr 22, 2004·The Journal of Allergy and Clinical Immunology·Cédric DeruazFrançois Spertini
Feb 8, 2006·The Journal of Allergy and Clinical Immunology·Anthony J FrewUNKNOWN UK Immunotherapy Study Group
Jan 23, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Harold NelsonMoises A Calderon
Jan 30, 2015·The New England Journal of Medicine·Lisa M Wheatley, Alkis Togias
Nov 14, 2019·Sensors·Juan Carlos Pereira-KohatsuMiguel Camacho-Collados
Dec 18, 2010·Expert Review of Clinical Immunology·Gian Enrico SennaMassimo Milani
Sep 7, 2015·Asthma Research and Practice·Maureen Egan, Supinda Bunyavanich
Sep 18, 2018·Current Treatment Options in Allergy·Martin PenagosGuy W Scadding
May 18, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Liang DaiZhao-Xiang Bian
Oct 16, 2015·International Forum of Allergy & Rhinology·Frederick M SchafferAndrew R Naples
Dec 15, 2020·Current Allergy and Asthma Reports·Gabija DrazdauskaitėMohamed H Shamji
Nov 15, 2001·The Journal of Allergy and Clinical Immunology·J BousquetUNKNOWN World Health Organization
Aug 28, 2021·Antioxidants·Munsoo HanTae Hoon Kim
Jan 29, 2020·Molecular Pharmaceutics·Sara BenedéEva Batanero
Sep 1, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Jin Youp KimDoo Hee Han

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.